Fabrice Beau

Statistics

Publications

Citations

1.6K

H-Index

Active since

1998

Affiliations

Commissariat à l'Énergie Atomique et aux Énergies Alternatives(Current)

CEA Paris-Saclay

National and Kapodistrian University of Athens

Centre National de la Recherche Scientifique

Université Paris-Saclay

Fabrice Beau is an author at Commissariat à l'Énergie Atomique et aux Énergies Alternatives specializing in pharmacology, enzyme inhibition, and biochemistry.

Publications per year

1998–2022

Publications

A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E–Knockout Mice

Jason L. Johnson, Laurent Devel, Bertrand Czarny et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2011 · 174 citations · Full text

Medicine, Cardiology, Pharmacology +14

Roles of the Two Active Sites of Somatic Angiotensin-Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin

Dimitris Georgiadis, Fabrice Beau, Bertrand Czarny et al. · Circulation Research · 2003 · 155 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +9

Development of Selective Inhibitors and Substrate of Matrix Metalloproteinase-12

Laurent Devel, Vassilis Rogakos, Arnaud David et al. · Journal of Biological Chemistry · 2006 · 149 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Phosphinic Pseudo-Tripeptides as Potent Inhibitors of Matrix Metalloproteinases: A Structure−Activity Study

Stamatia Vassiliou, Artur Mucha, Philippe Cuniasse et al. · Journal of Medicinal Chemistry · 1999 · 111 citations · Full text

Pharmacy, Biochemistry, Medicinal Chemistry +12

Phosphinic Tripeptides as Dual Angiotensin-Converting Enzyme C-Domain and Endothelin-Converting Enzyme-1 Inhibitors

Nicolas Jullien, Anastasios Makritis, Dimitris Georgiadis et al. · Journal of Medicinal Chemistry · 2009 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

1–5 of 34